Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: July 17, 2008
Last updated: August 8, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 5, 2013